[Perspectives] Innovation in gynaecological cancer: highlighting global disparities

Globally, a polarised epidemiological transition is occurring in cancer, generating a divide that reflects the inequity in access to all components of cancer care and control, now referred to as the cancer divide. Attempts to address the challenges these inequities create should acknowledge and incorporate inherent differences in disease burden, culture, and resources across the world (appendix pp 1–2). In high-income countries (HICs), increasing centralisation of cancer care in tertiary, or even supraregional, centres will further enhance access to high-quality surgery, diagnostics, radiotherapy, systemic therapies, and new technologies, which can offset their cost.